allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001
Term · Oncology and biomedicine · MLC-T-ONC-009859
A preparation of allogeneic CD8+ T cells targeting multiple undisclosed leukemia-associated antigens, with potential immunomodulating and antineoplastic activities. Following peripheral blood mononuclear cell (PBMC) collection from the original stem cell donor and ex vivo priming and expansion, the allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001 are re-introduced into the leukemia patient, where they target and kill tumor cells expressing these leukemia-associated antigens.
| Identifier | MLC-T-ONC-009859 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009859",
"term": "allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001",
"field": "Oncology and biomedicine",
"definition": "A preparation of allogeneic CD8+ T cells targeting multiple undisclosed leukemia-associated antigens, with potential immunomodulating and antineoplastic activities. Following peripheral blood mononuclear cell (PBMC) collection from the original stem cell donor and ex vivo priming and expansion, the allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001 are re-introduced into the leukemia patient, where they target and kill tumor cells expressing these leukemia-associated antigens.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-cd8-plus-leukemia-associated-antigens-specific-t-cells-nexi-001/"
}
Record 745 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.